There should be no surprise to biotech investors that the mergers and acquisition (M&A) market and chatter are heating up. The huge buy of Synageva Biopharma Corp. (NASDAQ: GEVA) by Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) could be just the start of what may be an exciting summer and rest of 2015 in the industry.
Hey, check out all the research scientist jobs. Post your resume today!
